Silverback Therapeutics Inc
Change company Symbol lookup
Select an option...
SBTX Silverback Therapeutics Inc
FSRXU Finserv Acquisition Corp II
ASPCU Alpha Capital Acquisition Co
EXPD Expeditors International of Washington Inc
NMIH NMI Holdings Inc
$NQUSS40301035EURT Nasdaq Small Cap Radio and TV Broadc
EPAY Bottomline Technologies Inc
QFTA Quantum FinTech Acquisition Corp
HON Honeywell International Inc
CTXS Citrix Systems Inc
Go

Health Care : Biotechnology |
Company profile

Silverback Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on ImmunoTAC technology platform to develop therapeutics for the treatment of cancer, chronic viral infections, and other diseases. Its ImmunoTAC platform includes three components, such as Antigen binding domain, Linker-payload, and Fc region. Its lead product candidate, SBT6050, is comprised of a Toll-like receptor 8 (TLR8) agonist linker-payload conjugated to a human epidermal growth factor receptor 2 (HER2)-directed monoclonal antibody that targets tumors including certain breast, gastric and non-small cell lung cancers. Its second product candidate, SBT6290, is comprised of a TLR8 agonist as a payload. SBT6290 is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4. Its third TLR8 program, SBT8230, is comprised of a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is for the treatment of chronic hepatitis B virus infection (cHBV).

Closing Price
$4.27
Day's Change
-0.26 (-5.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.68
Day's Low
4.24
Volume
(Above Average)
Volume:
316,923

10-day average volume:
275,474
316,923
  • Prev Close
    4.53
  • Today's Open
    4.60
  • Day's Range
    4.24-4.68
  • Avg Vol (10-day)
    275.5K
  • Last (time)
    4:00p ET 01/20/22
  • Last (size)
    87
  • 52-Wk Range
    4.24 - 63.41
    LowHigh
  • (03/18/21 - 01/20/22)
    0.71%
  • 83.8%
  • Market Cap
    150.0M
  • Shares Outstanding
    35.1M
  • -2.22
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 86.67
  • (% of float 12/31/21)
    4.89

Latest News

January 10, 2022
9:03 am ET
Globe Newswire
January 05, 2022
9:10 am ET
BusinessWire
January 04, 2022
3:10 pm ET
Globe Newswire
2:26 pm ET
Globe Newswire
1:40 pm ET
Newsfile
11:00 am ET
BusinessWire
10:03 am ET
Newsfile
9:15 am ET
Accesswire
8:00 am ET
Accesswire
January 03, 2022
7:42 pm ET
Newsfile
1:52 pm ET
PR Newswire
12:33 pm ET
Newsfile
11:03 am ET
Accesswire
10:02 am ET
Newsfile
8:31 am ET
Accesswire
January 02, 2022
10:25 pm ET
Newsfile
9:00 pm ET
BusinessWire
1:26 pm ET
Accesswire
11:00 am ET
Globe Newswire
8:17 am ET
Newsfile
January 01, 2022
4:30 pm ET
PR Newswire
December 31, 2021
5:18 pm ET
Newsfile
2:40 pm ET
PR Newswire
2:18 pm ET
Newsfile
8:41 am ET
Accesswire
December 30, 2021
9:00 pm ET
Globe Newswire
2:02 pm ET
Newsfile
12:01 pm ET
Accesswire
11:01 am ET
Accesswire
10:30 am ET
Accesswire
8:40 am ET
Accesswire
December 29, 2021
10:13 pm ET
Newsfile
10:10 pm ET
PR Newswire
2:41 pm ET
Accesswire
9:01 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.